Raby, J. | bioRxiv Science

bioRxiv2026

EpiATLAS - a reference for human epigenomic research

The sequence of the human genome provides a foundation for understanding cellular processes in health and disease1. The organisation of this primary genetic information into cell-specific structure and function is critical to understanding the cell type-specific interpretation and execution of the genome. Epigenetic processes are essential for packaging and higher-level functional organisation of the genome, and changes therein are increasingly recognised as contributors to human disease. Building on primary data generated by multinational consortia, the International Human Epigenome Consortium2 (IHEC) has uniformly processed a collection of more than 2000 comprehensive human reference epigenomes, collectively referred to as EpiATLAS. This effort involved the development of standardised molecular and bioinformatics protocols, metadata models, and analytical tools to manage, integrate, display, and share vast amounts of epigenomic data. This includes the creation of a publicly available Epigenome Reference Registry, which provides a system for accessing protected human subject datasets and facilitates open searching of de-identified samples and experimental data. The integrated EpiATLAS ecosystem and its comprehensive human reference epigenome maps provide an unprecedented resource for the biosciences, expanding the annotated epigenomic landscape while uncovering previously unappreciated relationships among regulatory layers and revealing how epigenetic inputs underpin fundamental cellular functions and disease associations.

genomics↗

bioRxiv2025

Leveraging the largest harmonized epigenomic data collection for metadata prediction validated and augmented over 350,000 public epigenomic datasets

Epigenomic data found in public databases often suffer from issues of non-standardization and incompleteness in their associated metadata. There are currently no automated approaches to validate or correct missing or inaccurate information listed in databases. To tackle this challenge, we harnessed the extensive harmonized data and metadata provided by the EpiATLAS project of the International Human Epigenome Consortium (IHEC) to train EpiClass, a suite of machine learning classifiers that can predict key metadata ([~]98% accuracy), including experimental assay, donor sex, biospecimen and sample cancer status. The development of these classifiers enabled the identification of a few mislabeled and low-quality datasets in the EpiATLAS project, while also completing with high-confidence most of the missing metadata. These classifiers were also validated on ENCODE datasets absent from the initial training, then applied to assess more than 350,000 human ChIP-Seq and RNA-Seq datasets from public repositories. Overall, this effort not only validated the accuracy of the vast majority of assays reported by the original authors, but also unveiled [~]500 datasets with discrepancies, in particular through data swap within series of experiments. More importantly, EpiClass also supplied high-confidence predictions for over 320,000 metadata attributes of the biological sample such as the sex, cancer status and biomaterial type, which had been originally omitted in the majority of cases. Our work introduces the first systematic approach for metadata correction and augmentation, enhancing the quality and reliability of publicly available epigenomic data.

bioinformatics↗